GenSight Biologics
Gene therapy for retinal diseases
- B2B
About GenSight Biologics
Innovative gene therapy company dedicated to developing novel treatments for severe retinal neurodegenerative diseases in a clinical-stage setting
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- paris, ile-de-france, France
- Founded
- 2013
- Revenue
- €1KFY2025, filed accounts, INPI
- Website
- gensight-biologics.com
GenSight Biologics at a glance
GenSight Biologics is a B2B company in the Biotechnology Research industry, headquartered in paris, ile-de-france, France.
GenSight Biologics was founded in 2013.
GenSight Biologics has 1–10 employees.
GenSight Biologics's revenue is €1K (FY2025, filed accounts, INPI).
Frequently asked questions about GenSight Biologics
What is GenSight Biologics's revenue?
GenSight Biologics's revenue is €1K (FY2025, filed accounts, INPI).
How many employees does GenSight Biologics have?
GenSight Biologics has 1–10 employees.
Where is GenSight Biologics headquartered?
GenSight Biologics is headquartered in paris, ile-de-france, France.
Selling to companies like GenSight Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies